Prevention of Progression in Chronic Liver Disease - An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Popper's 100th birthday (Hardcover, 2004 ed.)

In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40 per cent of patients with HCV genotype 1 and up to 20 per cent of patients with genotype 2 or 3. Several approaches are now underway to prevent or ameliorate mechanisms of disease progression. In Asia, and particularly in Japan, Glycyrrhizine-SNMC has been widely used for this purpose. At present, SNMC is under clinical evaluation in Europe.

General

Imprint:	Springer
Country of origin:	Netherlands
Series:	Falk Symposium, 138A
Release date:	July 2004
First published:	2004
Editors:	N. Hiyashi • M.P. Manns
Dimensions:	235 x 155 x 9mm (L x W x T)
Format:	Hardcover
Pages:	130
Edition:	2004 ed.
ISBN-13:	978-0-7923-8796-1
Categories:	Books > Medicine > Clinical & internal medicine > Hepatology
LSN:	0-7923-8796-1
Barcode:	9780792387961

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!